Guangzhou Restaurant Group Company Limited (603043.SS)
CNY 17.1
(-0.52%)
CNY 17.1
(-0.52%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1 Billion CNY | 14.87% |
| 2022 | 910.84 Million CNY | -1.4% |
| 2021 | 892.98 Million CNY | 40.38% |
| 2020 | 659.72 Million CNY | 22.74% |
| 2019 | 535.51 Million CNY | 3.24% |
| 2018 | 517.05 Million CNY | 12.21% |
| 2017 | 461.07 Million CNY | 18.85% |
| 2016 | 372.1 Million CNY | 15.85% |
| 2015 | 325.79 Million CNY | 1.75% |
| 2014 | 316.74 Million CNY | 12.53% |
| 2013 | 284.54 Million CNY | 8.5% |
| 2012 | 262.07 Million CNY | 29.74% |
| 2011 | 202.14 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 112.53 Million CNY | -32.97% |
| 2024 Q3 | 465.33 Million CNY | 1466.03% |
| 2024 Q2 | -36.36 Million CNY | -132.32% |
| 2023 Q2 | 28.11 Million CNY | -74.93% |
| 2023 Q4 | 73.03 Million CNY | -86.91% |
| 2023 FY | - CNY | 14.87% |
| 2023 Q1 | 112.16 Million CNY | 98.73% |
| 2023 Q3 | 557.91 Million CNY | 1884.46% |
| 2022 FY | - CNY | -1.4% |
| 2022 Q4 | 56.43 Million CNY | -89.46% |
| 2022 Q3 | 535.6 Million CNY | 8997.43% |
| 2022 Q2 | 5.88 Million CNY | -92.21% |
| 2022 Q1 | 75.53 Million CNY | -49.99% |
| 2021 Q1 | 60.93 Million CNY | -45.45% |
| 2021 Q4 | 151.04 Million CNY | -70.73% |
| 2021 Q3 | 516.01 Million CNY | 13524.63% |
| 2021 FY | - CNY | 40.38% |
| 2021 Q2 | -3.84 Million CNY | -106.31% |
| 2020 Q3 | 446.68 Million CNY | 14189.15% |
| 2020 FY | - CNY | 22.74% |
| 2020 Q4 | 111.71 Million CNY | -74.99% |
| 2020 Q2 | -3.17 Million CNY | -122.4% |
| 2020 Q1 | 14.15 Million CNY | -82.79% |
| 2019 Q4 | 82.22 Million CNY | -76.09% |
| 2019 Q3 | 343.92 Million CNY | 3197.43% |
| 2019 FY | - CNY | 3.24% |
| 2019 Q1 | 57.72 Million CNY | -48.29% |
| 2019 Q2 | -11.1 Million CNY | -119.24% |
| 2018 Q2 | 6.39 Million CNY | -86.92% |
| 2018 Q1 | 48.89 Million CNY | -65.89% |
| 2018 FY | - CNY | 12.21% |
| 2018 Q4 | 111.62 Million CNY | -62.87% |
| 2018 Q3 | 300.65 Million CNY | 4602.07% |
| 2017 Q3 | 229.44 Million CNY | 167.49% |
| 2017 Q1 | 385.01 Million CNY | 304.45% |
| 2017 Q2 | -339.99 Million CNY | -188.31% |
| 2017 FY | - CNY | 18.85% |
| 2017 Q4 | 143.32 Million CNY | -37.54% |
| 2016 Q2 | -286.79 Million CNY | -190.36% |
| 2016 Q3 | 221.62 Million CNY | 177.28% |
| 2016 Q1 | 317.4 Million CNY | 0.0% |
| 2016 FY | - CNY | 15.85% |
| 2016 Q4 | 95.19 Million CNY | -57.05% |
| 2015 FY | - CNY | 1.75% |
| 2014 Q1 | 19.28 Million CNY | 0.0% |
| 2014 FY | - CNY | 12.53% |
| 2014 Q4 | 136.15 Million CNY | 0.0% |
| 2014 Q3 | 136.15 Million CNY | 606.13% |
| 2014 Q2 | 19.28 Million CNY | 0.0% |
| 2013 FY | - CNY | 8.5% |
| 2012 FY | - CNY | 29.74% |
| 2011 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd | 39.62 Million CNY | -2440.348% |